Serratia marcescens meningitis: Epidemiology, prognostic factors and treatment outcomes

Journal of Microbiology, Immunology and Infection

Volumn 46, Issue 4, 2013, Pages 259-265

  Wu, Yen Mu ^a   Hsu, Po Chang ^a   Yang, Chien Chang ^a   Chang, Hong Jyun ^a   Ye, Jung Jr ^a   Huang, Ching Tai ^a   Lee, Ming Hsun ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Lactate; Meningitis; Outcome; Serratia marcescens

Indexed keywords

C REACTIVE PROTEIN; CARBAPENEM; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; FLOMOXEF; IMIPENEM; LACTIC ACID; MEROPENEM;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BRAIN TUMOR; CEREBROSPINAL FLUID; CLINICAL ARTICLE; EPIDEMIOLOGICAL DATA; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE UNIT; MALE; MENINGITIS; MORTALITY; NEUROSURGERY; PROGNOSIS; PROTEIN BLOOD LEVEL; SERRATIA MARCESCENS; SOLID TUMOR; TREATMENT OUTCOME;

EID: 84882240878     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.07.006     Document Type: Article

References (37)

1. Abbott S.L. Klebsiella, Enterobacter, Citrobacter, Serratia, Plesiomonas, and other Enterobacteriaceae. Manual of clinical microbiology 2007, 698-711. American Society of Microbiology, Washington, DC. 9th ed. P.R. Murray, E.J. Baron, J.H. Jorgensen, M.A. Pfaller, R.H. Yolken (Eds.).
2. Passaro D.J., Waring L., Armstrong R., Bolding F., Bouvier B., Rosenberg J., et al. Postoperative Serratia marcescens wound infections traced to an out-of-hospital source. J Infect Dis 1997, 175:992-995.
3. Vigeant P., Loo V.G., Bertrand C., Dixon C., Hollis R., Pfaller M.A., et al. An outbreak of Serratia marcescens infections related to contaminated chlorhexidine. Infect Control Hosp Epidemiol 1998, 19:791-794.
4. Okuda T., Endo N., Osada Y., Zen-Yoji H. Outbreak of nosocomial urinary tract infections caused by Serratia marcescens. J Clin Microbiol 1984, 20:691-695.
5. Villarino M.E., Jarvis W.R., O'Hara C., Bresnahan J., Clark N. Epidemic of Serratia marcescens bacteremia in a cardiac intensive care unit. J Clin Microbiol 1989, 27:2433-2436.
6. Chemaly R.F., Rathod D.B., Sikka M.K., Hayden M.K., Hutchins M., Horn T., et al. Serratia marcescens bacteremia because of contaminated prefilled heparin and saline syringes: A multi-state report. Am J Infect Control 2011, 39:521-524.
7. K[U+04E7]rner R.J., Nicol A., Reeves D.S., MacGowan A.P., Hows J. Ciprofloxacin resistant Serratia marcescens endocarditis as a complication of non-Hodgkin's lymphoma. J Infect 1994, 29:73-76.
8. Johnson J.S., Croall J., Power J.S.F., Armstrong G.R. Fatal Serratia marcescens meningitis and myocarditis in a patient with an indwelling urinary catheter. J Clin Pathol 1998, 51:789-790.
9. Peeters A., Vandercam B., Sindic C.J., Hantson P., Mahieu P. Community-acquired Serratia marcescens meningitis. J Infect 1997, 35:303-304.
10. Lu C.H., Chang W.N., Chuang Y.C., Chang H.W. The prognostic factors of adult gram-negative bacillary meningitis. J Hosp Infect 1998, 40:27-34.
11. Morris A., Low D.E. Nosocomial bacterial meningitis, including central nervous system shunt infections. Infect Dis Clin North Am 1999, 13:735-750.
12. Huang C.R., Lu C.H., Chien C.C., Chang W.N. Protean infectious types and frequent association with neurosurgical procedures in adult Serratia marcescens CNS infections: report of two cases and review of the literature. Clin Neurol Neurosurg 2001, 103:171-174.
13. Chang W.N., Lu C.H., Huang C.R., Tsai N.W., Chuang Y.C., Chang C.C., et al. Changing epidemiology of adult bacterial meningitis in southern Taiwan: a hospital-based study. Infection 2008, 36:15-22.
14. Parodi S., Lechner A., Osih R., Vespa P., Pegues D. Nosocomial Enterobacter meningitis: risk factors, management, and treatment outcomes. Clin Infect Dis 2003, 37:159-166.
15. Bremer A.A., Darouiche R.O. Ventriculoperitoneal shunt infection due to Serratia marcescens. J Infect 2005, 50:138-141.
16. Chang C.J., Ye J.J., Yang C.C., Huang P.Y., Chiang P.C., Lee M.H. Influence of third-generation cephalosporin resistance on adult in-hospital mortality from post-neurosurgical bacterial meningitis. J Microbiol Immunol Infect 2010, 43:301-309.
17. Tunkel A.R., Hartman B.J., Kaplan S.L., Kaufman B.A., Roos K.L., Scheld W.M., et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004, 39:1267-1284.
18. Sakushima K., Hayashino Y., Kawaguchi T., Jackson J.L., Fukuhara S. Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: a meta-analysis. J Infect 2011, 62:255-262.
19. O'Neill E., Humphreys H., Phillips J., Smyth E.G. Third-generation cephalosporin resistance among Gram-negative bacilli causing meningitis in neurosurgical patients: significant challenges in ensuring effective antibiotic therapy. J Antimicrob Chemother 2006, 57:356-359.
20. Durand M.L., Calderwood S.B., Weber D.J., Miller S.I., Southwick F.S., Caviness V.S., et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993, 328:21-28.
21. Jones A.E., Trzeciak S., Kline J.A. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 2009, 37:1649-1654.
22. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement 2011, CLSI, Wayne, PA, CLSI document M100-S21.
23. Fang C.T., Chen Y.C., Chang S.C., Sau W.Y., Luh K.T. Klebsiella pneumoniae meningitis: timing of antimicrobial therapy and prognosis. QJM 2000, 93:45-53.
24. Huang C.R., Lu C.H., Chuang Y.C., Tsai N.W., Chang C.C., Chen S.F., et al. Adult Pseudomonas aeruginosa meningitis: high incidence of underlying medical and/or postneurosurgical conditions and high mortality rate. Jpn J Infect Dis 2007, 60:397-399.
25. Foster D.R., Rhoney D.H. Enterobacter meningitis: organism susceptibilities, antimicrobial therapy and related outcomes. Surg Neurol. 2005, 63:533-537.
26. Chen S.F., Chang W.N., Lu C.H., Chuang Y.C., Tsai H.H., Tsai N.W., et al. Adult Acinetobacter meningitis and its comparison with non-Acinetobacter gram-negative bacterial meningitis. Acta Neurol Taiwan 2005, 14:131-137.
27. Haddy R.I., Mann B.L., Nadkarni D.D., Cruz R.F., Elshoff D.J., Buendia F.C., et al. Nosocomial infection in the community hospital: severe infection due to Serratia species. J Fam Prac 1996, 42:273-277.
28. Korshin A., Køster-Rasmussen R., Meyer C.N. Danish Bacterial Meningitis Group. Adjunctive steroid treatment: local guidelines and patient outcome in adult bacterial meningitis. Scand J Infect Dis 2007, 39:963-968.
29. Genton B., Berger J.P. Cerebrospinal fluid lactate in 78 cases of adult meningitis. Intensive Care Med 1990, 16:196-200.
30. Huy N.T., Thao N.T., Diep D.T., Kikuchi M., Zamora J., Hirayama K. Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis. Crit Care 2010, 14:R240.
31. Leib S.L., Boscacci R., Gratzl O., Zimmerli W. Predictive value of cerebrospinal fluid (CSF) lactate level versus CSF/blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery. Clin Infect Dis 1999, 29:69-74.
32. Aggarwal A.P., Kumar M., Avasthi G., Soni R.K. Diagnostic and prognostic significance of lactate dehydrogenase in cerebrospinal fluid in patients of meningitis. J Indian Med Assoc 1994, 92:288-290.
33. Imuekehme S., Obi J., Alakija W. Cerebro-spinal lactate status in childhood pyogenic meningitis in Nigeria. J Trop Pediatr 1997, 43:361-363.
34. Luzzaro F., Perilli M., Migliavacca R., Lombardi G., Micheletti P., Agodi A., et al. Repeated epidemics caused by extended-spectrum beta-lactamase-producing Serratia marcescens strains. Eur J Clin Microbiol Infect Dis 1998, 17:629-636.
35. Bonnet R., Sampaio J.L., Chanal C., Sirot D., De Champs C., Viallard J.L., et al. A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in Brazil. Antimicrob Agents Chemother 2000, 44:3061-3068.
36. Ivanova D., Markovska R., Hadjieva N., Schneider I., Mitov I., Bauernfeind A. Extended-spectrum β-lactamase-producing Serratia marcescens outbreak in a Bulgarian hospital. J Hosp Infection 2008, 70:60-65.
37. Kaufman B.A. Infections of cerebrospinal fluid shunts. Infections of the central nervous system 1997, 555-577. Lippincott-Raven, Philadelphia, PA. 2nd ed. W.M. Scheld, R.J. Whitley, D.T. Durack (Eds.).